Gene · 2669
Papers2,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Can venture capital shareholding improve M&A performance? An empirical study based on Chinese GEM-listed companies. | PLoS One | 2024 | 39146381 | PubTator, text mining | PubMed |
| Causal associations of physical activity and leisure sedentary behaviors with age at onset of Huntington's disease: A mendelian randomization study. | Parkinsonism Relat Disord | 2024 | 39096550 | PubTator, text mining | PubMed |
| Transcriptomic Plasticity of the Circadian Clock in Response to Photoperiod: A Study in Male Melatonin-Competent Mice. | J Biol Rhythms | 2024 | 39096022 | PubTator, text mining | PubMed |
| Recruited atypical Ly6G+ macrophages license alveolar regeneration after lung injury. | Sci Immunol | 2024 | 39093958 | PubTator, text mining | PubMed |
| A nanoparticle vaccine displaying varicella-zoster virus gE antigen induces a superior cellular immune response than a licensed vaccine in mice and non-human primates. | Front Immunol | 2024 | 39081325 | PubTator, text mining | PubMed |
| Adding metabolic tasks to human GEM models to improve the study of gene targets and their associated toxicities. | Sci Rep | 2024 | 39068208 | PubTator, text mining | PubMed |
| An imbalanced learning method based on graph tran-smote for fraud detection. | Sci Rep | 2024 | 39019984 | PubTator, text mining | PubMed |
| Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome in patients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial. | Haematologica | 2024 | 38988266 | PubTator, text mining | PubMed |
| GEM-based computational modeling for exploring metabolic interactions in a microbial community. | PLoS Comput Biol | 2024 | 38900842 | PubTator, text mining | PubMed |
| gMCSpy: efficient and accurate computation of genetic minimal cut sets in Python. | Bioinformatics | 2024 | 38748994 | PubTator, text mining | PubMed |
| Innovative use of a syringe needle cover in hair transplantation. | Skin Res Technol | 2024 | 38720480 | PubTator, text mining | PubMed |
| Metal coordination nanotheranostics mediated by nucleoside metabolic inhibitors potentiate STING pathway activation for cancer metalloimmunotherapy. | J Control Release | 2024 | 38685387 | PubTator, text mining | PubMed |
| Perspectives on Genetically Engineered Microorganisms and Their Regulation in the United States. | ACS Synth Biol | 2024 | 38669097 | PubTator, text mining | PubMed |
| On the accuracy of sequence methods for baroreflex sensitivity estimation. | Phys Eng Sci Med | 2024 | 38564152 | PubTator, text mining | PubMed |
| Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group. | ESMO Open | 2024 | 38503144 | PubTator, text mining | PubMed |
| Study on the impact of digital transformation on the innovation potential based on evidence from Chinese listed companies. | Sci Rep | 2024 | 38485982 | PubTator, text mining | PubMed |
| First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma. | Int J Mol Sci | 2024 | 38473827 | PubTator, text mining | PubMed |
| Impact of DREAMS interventions on attitudes towards gender norms among adolescent girls and young women: Findings from a prospective cohort in Kenya. | PLOS Glob Public Health | 2024 | 38446820 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals Coexpression Networks and Hub Genes Involved in Papillae Development in Lilium auratum. | Int J Mol Sci | 2024 | 38397114 | PubTator, text mining | PubMed |
Selinexor, daratumumab, bortezomib and dexamethasone for the treatment of patients with relapsed or refractory multiple myeloma: results of the phase II, nonrandomized, multicenter GEM-SELIBORDARA study. | Haematologica | 2024 | 38356463 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2669/papers?page=9